跳至主要内容
临床试验/CTRI/2022/01/039594
CTRI/2022/01/039594尚未招募未知

Prospective, open-label, single-arm, multicentre, observational, postmarketing clinical study to evaluate safety and performance of multifocal hydrophobic acrylic foldable intraocular lens (IOL) (Omni Lens Pvt. Ltd.) in patients who require IOL implantation during routine cataract surgery. - NA

Omni Lens Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Patient aged greater than or equal to 40 years at the time of enrolment
  • 2. A patient who receive multifocal hydrophobic acrylic foldable IOL (Omni Lens Pvt. Ltd.) as per the instruction mentioned in instructions
  • for use (IFU) of the study device during routine cataract surgery
  • 3. Clear intraocular media other than cataract
  • 4. Calculated IOL power is within the range of the study device
  • 5. The patient or his/her legally authorized representative (if applicable)
  • agrees to provide written informed consent
  • 6. The patient is willing to comply with protocol specified follow-up
  • evaluations

排除标准

  • 1. Patient with contraindications for Multifocal IOL mentioned in the
  • IFU of the study device
  • 2. previous intraocular or corneal surgery
  • 3. traumatic cataract
  • 4. pregnancy or lactation
  • 5. instability of keratometry or biometry measurements
  • 6. irregular astigmatism
  • 7. more than 1 D of pre-operative corneal astigmatism
  • 8. Currently participating in another clinical study with experimental
  • drugs or devices
  • 9. Unsuitable for study participation for any other reason, as determined
  • by Investigators clinical judgment (reason to be documented on CRF)
  • 10. Active SARS-CoV-2 infection known to Patient at the time of
  • enrolment in the study/ patients having signs and symptoms of SARSCoV-
  • 2 infection at the time of enrolment
  • Patients shall be discontinued when certain conditions are present at the time
  • of surgery, including:
  • zonular instability;
  • need for iris manipulation;
  • capsular fibrosis or other opacity; and
  • inability to fixate IOL in the desired position.
  • In such cases, the patient shall be followed until the condition has stabilized.

研究者

发起方
Omni Lens Pvt Ltd

相似试验